▶ 調査レポート

心臓再同期治療システムの世界市場分析・規模・シェア・成長・動向・予測:製品別

• 英文タイトル:Cardiac Resynchronization Therapy Systems Market (Product - Cardiac Resynchronization Therapy Pacemaker, Cardiac Resynchronization Therapy Defibrillator) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Transparency Market Researchが調査・発行した産業分析レポートです。心臓再同期治療システムの世界市場分析・規模・シェア・成長・動向・予測:製品別 / Cardiac Resynchronization Therapy Systems Market (Product - Cardiac Resynchronization Therapy Pacemaker, Cardiac Resynchronization Therapy Defibrillator) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025 / TPM-B04250資料のイメージです。• レポートコード:TPM-B04250
• 出版社/出版日:Transparency Market Research / 2018年3月
• レポート形態:英文、PDF、156ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥637,450 (USD5,795)▷ お問い合わせ
  Multi User¥967,450 (USD8,795)▷ お問い合わせ
  Global Site License¥1,297,450 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、心臓再同期治療システムの世界市場について調べ、心臓再同期治療システムの世界規模、市場動向、市場環境、製品別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・心臓再同期治療システムの世界市場動向
・心臓再同期治療システムの世界市場環境
・心臓再同期治療システムのバリューチェーン分析
・心臓再同期治療システムの世界市場規模
・心臓再同期治療システムの世界市場規模:製品別
・心臓再同期治療システムの世界市場:地域別市場規模・分析
・心臓再同期治療システムの北米市場規模・予測
・心臓再同期治療システムのアメリカ市場規模・予測
・心臓再同期治療システムの中南米市場規模・予測
・心臓再同期治療システムのヨーロッパ市場規模・予測
・心臓再同期治療システムのアジア市場規模・予測
・心臓再同期治療システムの日本市場規模・予測
・心臓再同期治療システムの中国市場規模・予測
・心臓再同期治療システムのインド市場規模・予測
・心臓再同期治療システムの中東市場規模・予測
・心臓再同期治療システムのアフリカ市場規模・予測
・競争状況・関連企業情報

Request Report Methodology
Global Cardiac Resynchronization Therapy Systems Market: Scope and Methodology

This report on the global Cardiac Resynchronization Therapy Systems Market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global diabetes devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global diabetes devices market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of various segments of global Cardiac Resynchronization Therapy Systems Market.

Cardiac Resynchronization Therapy Systems Market: Segmentation

Prevalence of heart failure is expected to increase exponentially worldwide due to change in lifestyle and various factors such as malnutrition, genetic mutations, and others. According to various government and private organizations operating in the cardiovascular industry, heart failure is considered one of the top reasons of mortality worldwide. Globally 26 million people are affected by heart failure. Cardiac resynchronization therapy (CRT) systems are used to treat conditions such as heart failure. The global Cardiac Resynchronization Therapy Systems Market can be segmented based on product type and region.

Depending on the product type the global Cardiac Resynchronization Therapy Systems Market includes – Cardiac Resynchronization Therapy Pacemaker and Cardiac Resynchronization Therapy Defibrillator. Cardiac resynchronization therapy pacemaker (CRT-P) also known as bi ventricular pacing is an implantable cardiac resynchronization therapy (CRT) pacemaker for patients with heart failure. The device monitors the heart’s rhythm, detects irregularities and corrects them with electrical impulses. Cardiac resynchronization therapy defibrillator (CRT-D) is implanted in heart failure patients who are at a high risk of sudden cardiac arrest.

Cardiac Resynchronization Therapy Systems Market: Geographical and Competitive Dynamics

Geographically, the global Cardiac Resynchronization Therapy Systems Market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the Cardiac Resynchronization Therapy Systems Market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Medtronic, Boston Scientific Corporation, Abbott, LivaNova PLC, BIOTRONIK SE & Co. KG

The global Cardiac Resynchronization Therapy Systems Market is segmented as follows:

Global Cardiac Resynchronization Therapy Systems Market Revenue, by Product type

Cardiac Resynchronization Therapy Pacemaker
Cardiac Resynchronization Therapy Defibrillator
Global Cardiac Resynchronization Therapy Systems Market Revenue, by Geography

North America
US
Canada
Europe
Germany
France
Italy
Spain
UK
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Mexico
Rest of Latin America

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Research Approach & Methodology

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Global Diabetes Device Market Analysis and Forecasts, 2017–2025
4.3. Global Cardiac Resynchronization Therapy Systems Market Outlook
4.4. Porter’s Five Forces Analysis
4.5. Value Chain Analysis
4.6. Global Prevalence of Heart Failure
4.7. Recommendations for Cardiac Resynchronization Therapy (CRT)
4.8. Regulatory Framework

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends

6. Global Cardiac Resynchronization Therapy Systems Market Analysis, and Forecast by Product Type
6.1. Introduction & Definition
6.2. Global Cardiac Resynchronization Therapy Systems Market Analysis, by Product Type
6.2.1. Global Cardiac Resynchronization Therapy Systems Market Forecast, by Product Type
6.2.2. Cardiac Resynchronization Therapy Pacemaker
6.2.3. Cardiac Resynchronization Therapy Defibrillator

7. Global Cardiac Resynchronization Therapy Systems Market Analysis and Forecasts, By Region
7.1. Global Cardiac Resynchronization Therapy Systems Snapshot, by Country
7.2. Market Value Forecast By Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Middle East & Africa
7.3.5. Latin America
7.4. Market Attractiveness By Country/Region

8. North America Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Trends
8.2. Market Value Forecast By Product Type , 2017–2025
8.2.1. Cardiac Resynchronization Therapy Pacemaker
8.2.2. Cardiac Resynchronization Therapy Defibrillator
8.3. Market Value Forecast By Country , 2017–2025
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Product Type
8.4.2. By Country

9. Europe Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Trends
9.2. Market Value Forecast By Product Type , 2017–2025
9.2.1 Cardiac Resynchronization Therapy Pacemaker
9.2.2. Cardiac Resynchronization Therapy Defibrillator
9.3. Market Value Forecast By Country , 2017–2025
9.3.1. Germany
9.3.2. France
9.3.3. Italy
9.3.4. Spain
9.3.5. U.K.
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Product Type
9.4.2. By Country

10. Asia Pacific Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Trends
10.2. Market Value Forecast By Product Type , 2017–2025
10.2.1. Cardiac Resynchronization Therapy Pacemaker
10.2.2. Cardiac Resynchronization Therapy Defibrillator
10.3. Market Value Forecast By Country , 2017–2025
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Product Type
10.4.2. By Country

11. Middle East & Africa Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Trends
11.2. Market Value Forecast By Product Type, 2017–2025
11.2.1. Cardiac Resynchronization Therapy Pacemaker
11.2.2. Cardiac Resynchronization Therapy Defibrillator
11.3. Market Value Forecast By Country, 2017–2025
11.3.1. GCC Countries
11.3.2. South Africa
11.3.3. Rest of MEA
11.4. Market Attractiveness Analysis
11.4.1. By Product Type
11.4.2. By Country

12. Latin America Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Trends
12.2. Market Value Forecast By Product Type, 2017–2025
12.2.1. Cardiac Resynchronization Therapy Pacemaker
12.2.2. Cardiac Resynchronization Therapy Defibrillator
12.3. Market Value Forecast By Country, 2017–2025
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Market Attractiveness Analysis
12.4.1. By Product Type
12.4.2. By Country

13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.2.1. Medtronic
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Financial Overview
13.2.1.3. Product Portfolio
13.2.1.4. SWOT Analysis
13.2.1.5. Strategic Overview
13.2.2. Boston Scientific Corporation
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Financial Overview
13.2.2.3. Product Portfolio
13.2.2.4. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3. Abbott
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Financial Overview
13.2.3.3. Product Portfolio
13.2.3.4. SWOT Analysis
13.2.3.5. Strategic Overview
13.2.4. LivaNova PLC
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Financial Overview
13.2.4.3. Product Portfolio
13.2.4.4. SWOT Analysis
13.2.4.5. Strategic Overview
13.2.5. BIOTRONIK SE & Co. KG
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Financial Overview
13.2.5.3. Product Portfolio
13.2.5.4. SWOT Analysis
13.2.5.5. Strategic Overview
13.2.6. Asahi Kasei Medical Co., Ltd.
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Financial Overview
13.2.6.3. Product Portfolio
13.2.6.4. SWOT Analysis
13.2.6.5. Strategic Overview
13.2.7. NIHON KOHDEN CORPORATION
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Financial Overview
13.2.7.3. Product Portfolio
13.2.7.4. SWOT Analysis
13.2.7.5. Strategic Overview
13.2.8. Schiller AG
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Financial Overview
13.2.8.3. Product Portfolio
13.2.8.4. SWOT Analysis
13.2.8.5. Strategic Overview

List of Tables

Table 01: Opportunity Map, 2016
Table 02: Global Prevalence of Heart Failure (2015)
Table 03: Global Cardiac Resynchronization Therapy Systems Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 04: Global Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Cardiac Resynchronization Therapy Systems Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 06 North America Cardiac Resynchronization Therapy Systems Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 07: Europe Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 08: Europe Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 09: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 10: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 11: Latin America Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 12: Latin America Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 13: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 14: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Medtronic, Products & Services Offered
Table 16: Medtronic Recent Developments
Table 17 :Boston Scientific Corporation, Products & Services Offered
Table 18: Boston Scientific Corporation, Recent Developments
Table 19: Abbott, Products & Services Offered
Table 20: Abbott, Recent Developments
Table 21: LivaNova PLC, Products & Services Offered
Table 22: LivaNova PLC , Recent Developments
Table 23: BIOTRONIK SE & Co. KG , Products & Services Offered
Table 24: Asahi Kasei Medical Co., Ltd., Products & Services Offered
Table 25: Asahi Kasei Medical Co., Ltd., Recent Developments and Achievements
Table 26: NIHON KOHDEN CORPORATION, Products Offered
Table 27: NIHON KOHDEN CORPORATION, Recent Developments
Table 28: Schiller, Products Offered